The Neuro Experience

Why GLP-1s Are More Than a Weight Loss Drug | ft. Dr. Rocio Salas-Whalen

39 snips
Oct 7, 2025
Dr. Rocio Salas-Whalen, a triple board-certified endocrinologist and obesity medicine expert, shares her insights on the groundbreaking GLP-1 therapies. She discusses how these medications can combat obesity, reduce inflammation, and potentially lower Alzheimer's and cancer risks. Dr. Salas-Whalen also explores the connection between estrogen, menopause, and weight gain, emphasizing a shift in patient goals from appearance to strength. Tune in for her take on the future of GLP-1 innovations and her upcoming book, 'Weightless.'
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
INSIGHT

GLP-1 Is A Widespread Gut Hormone

  • GLP-1 is a gut hormone released by L cells after eating and acts on receptors throughout the body.
  • Synthetic GLP-1 analogs are long-acting versions that avoid rapid DPP-4 breakdown and reach the brain and other organs.
INSIGHT

Drugs Quiet Food Reward Pathways

  • GLP-1 drugs reduce food-driven reward by acting on brain reward centers like the amygdala.
  • This reduces cravings and interrupts habitual reward-seeking eating behaviors.
INSIGHT

Visceral Fat Drives Inflammation

  • Visceral fat is pro-inflammatory and drives chronic disease risk.
  • GLP-1s reduce visceral fat by cutting caloric intake and lowering consumption of pro-inflammatory foods rapidly.
Get the Snipd Podcast app to discover more snips from this episode
Get the app